SCHEMBL6259174

SCHEMBL6259174

CCN(Cc1ccccc1Oc1ccccc1)c1ccc(OC(=O)O)nn1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 6/20 0.45
▸ SLC6A2 P23975 5/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SLC6A3 Q01959 4/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ TSPO P30536 5/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ SLC1A5 Q15758 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ ALB P02768 1/20 0.37
▸ RIPK1 Q13546 1/20 0.36
▸ P2RX3 P56373 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259172 0.84 SLC6A4 (0.47) SLC6A4SLC6A2SMN1; SMN2L3MBTL1SLC6A3
SCHEMBL6262892 0.82 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3CYP2D6TSPO
SCHEMBL6260236 0.76 HCAR3 (0.51) SLC6A4SLC6A2SLC6A3CYP2D6TSPO
SCHEMBL8154853 0.74 PTGER1 (0.46) LMNA
SCHEMBL6257686 0.74 TSPO (0.43) SLC6A4SLC6A2L3MBTL1SLC6A3TSPO
SCHEMBL6261423 0.66 L3MBTL1 (0.38) SLC6A4L3MBTL1CYP2D6
SCHEMBL327806 0.65 SLC6A4 (0.63) SLC6A4SLC6A2L3MBTL1SLC6A3LMNA
SCHEMBL6260558 0.65 AOC3 (0.41) SMN1; SMN2L3MBTL1
Butane SCHEMBL6289475 0.65 CTNNB1 (0.51) SMN1; SMN2L3MBTL1TSPOLMNAMAPT
Hydrogen Sulfide SCHEMBL28150140 0.64 SLC6A4 (0.61) SLC6A4SLC6A2L3MBTL1SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0752421-B1 Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists ASTRAZENECA AB (SE) 2005-10-12 — — EP claimed
Send feedback